Home | Partnership | Careers | Contact Us | Location Map | Sign In
   
 
   
 
 
 
Home >> About Us > Success Story
E-mail this page Print this page

2008

  • Foray into Healthcare Delivery –collaboration to set-up 220 bed multi super-specialty hospital in NCR
  • WHO prequalification for fully liquid innovative combination Pentavalent vaccine, EasyFive* against five deadly infectious diseases (DTwP+ Hep B+ Hib) of early childhood.
  • Granted a patent from US Patent & Trademark Office for our product Thank GodTM (Euphorbia Prostrata) for effective management of hemorrhoids & piles (Patent No. 7,371,412 B2)

2007

  • Vaccine Formulation Plant at Baddi
  • Research Agreement with Punjab University to develop New Chemical Entities for Psychiatric Disorders

2006

  • WHO cGMP complaint ultra modern Pharmaceuticals formulation facility at Baddi, Himachal Pradesh.
  • Landmark collaborations with The Netherlands Vaccine Institute (The Nederlands Vaccin Instituut (NVI)) for manufacture & marketing of finished Inactivated Polio Vaccine (IPV) and a number of IPV based combination vaccines in India and across the globe.
  • Collaboration with PT.Bio Farma to manufacture & market Measles Vaccine.
  • Inauguration of Biopharmaceutical R&D Centre at New Delhi
  • Pre-Qualification Certification from WHO for Supply of Recombinant Hepatitis-B Vaccine to UN Agencies.
  • Collaboration with National Research Development Corporation (NRDC) for technology transfer of Foot and Mouth Vaccine.

2005

In-licensing agreement with National Institute of Health, USA for Hair Growth Hormone

2004

Collaboration with Cambridge Bio-stability, UK, for Thermo Stable Vaccines

2004

Marketing Joint Venture with Chiron (now Novartis) Vaccines, UK

2004

In-licensing agreement with National Institute of Immunology, New Delhi, for Japanese Encephalitis Candidate Vaccine

2002

Commissioning of Recombinant Vaccine Production Plant

2002

In-licensing Agreement with Biotechnology Consortium of India for Development & Commercialization of Anthrax Vaccine

2001

R&D tie up with European MNC

1997

First Product Patent in Several Countries

1995

State -of the- art Drug Delivery R&D centre at Lalru

1995

IPO of Equity Shares of Rs.180 Million

1993

Merger of Panacea Drugs (P) Ltd. & Radicura Pharma to form Panacea Biotec Ltd.

1989

Pharmaceutical formulations plant at New Delhi,under the name of  Panacea Drug P Ltd.

1988

Established a plant for vaccines production at New Delhi, under the name of Radicura Pharma

1984

Panacea Drug (P) Ltd. was formed